JESSICA ALVAREZ: Open Payments
NPI 1053152793 · CHESTERFIELD, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,408 in 111 payments from 20 companies in 2025. Trend: 2023 $0 · 2024 $274 · 2025 $2,408
Food & beverage: $2,324Education: $84
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 37 | $747 |
| Janssen Biotech, Inc. | 13 | $357 |
| PFIZER INC. | 10 | $174 |
| Aimmune Therapeutics, Inc. | 8 | $150 |
| QOL Medical, LLC | 6 | $132 |
| Regeneron Healthcare Solutions, Inc. | 4 | $122 |
| Gilead Sciences, Inc. | 5 | $119 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $108 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $89 |
| Ardelyx, Inc. | 4 | $69 |
Products named: TREMFYA, RINVOQ, LINZESS, SKYRIZI, DUPIXENT, Sucraid, XELJANZ, XIFAXAN.
Industry payments across MO — which companies pay providers there.
